Minimal residual disease quantification using consensus primers and high-throughput IGH sequencing predicts post-transplant relapse in chronic lymphocytic leukemia.

Logan, A C

Minimal residual disease quantification using consensus primers and high-throughput IGH sequencing predicts post-transplant relapse in chronic lymphocytic leukemia. [electronic resource] - Leukemia Aug 2013 - 1659-65 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1476-5551

10.1038/leu.2013.52 doi


Adult
Aged
Female
Follow-Up Studies
Hematopoietic Stem Cell Transplantation
High-Throughput Nucleotide Sequencing
Humans
Immunoglobulin Heavy Chains--genetics
Leukemia, Lymphocytic, Chronic, B-Cell--diagnosis
Male
Middle Aged
Neoplasm, Residual--diagnosis
Prognosis
Recurrence
Reproducibility of Results
Time Factors